JP MORGAN/CALL/LEIDOS/160/0.1/20.12.24 Share Price

Warrant

DE000JK8GSA8

Market Closed - Börse Stuttgart 01:12:26 31/05/2024 pm IST
0.96 EUR -3.03% Intraday chart for JP MORGAN/CALL/LEIDOS/160/0.1/20.12.24
Date Price Change
31/24/31 0.96 -3.03%
30/24/30 0.99 -11.61%
29/24/29 1.12 -15.79%
28/24/28 1.33 -0.75%
27/24/27 1.34 +8.06%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 01:12 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying LEIDOS HOLDINGS, INC.
Issuer J.P. Morgan
WKN JK8GSA
ISINDE000JK8GSA8
Date issued 02/05/2024
Strike 160 $
Maturity 20/12/2024 (202 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.45
Lowest since issue 0.93
Delta0.46x
Omega 5.513
Premium17.22x
Gearing11.89x
Moneyness 0.9191
Difference Strike 12.95 $
Difference Strike %+8.09%
Spread 0.1
Spread %8.40%
Theoretical value 1.140
Implied Volatility 37.09 %
Total Loss Probability 64.01 %
Intrinsic value 0.000000
Present value 1.140
Break even 172.37 €
Theta-0.03x
Vega0.04x
Rho0.03x

Company Profile

Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows: - defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.; - civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.; - health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc. Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%). The United States accounts for 91,4% of net sales.
Sector
-
More about the company

Ratings for Leidos Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Leidos Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
147 USD
Average target price
158.5 USD
Spread / Average Target
+7.76%
Consensus